Ubs Global Asset Management Americas »

Aurinia Pharmaceuticals shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 160k 8.99
2023-09-30 $1.1M 148k 7.77
2023-06-30 $1.6M 149k 10.96
2023-03-31 $1.6M 149k 10.96
2022-12-31 $615k 142k 4.32
2022-09-30 $683k 91k 7.52
2022-06-30 $1.0M 100k 10.05
2022-03-31 $653k 53k 12.38
2021-12-31 $3.2M 142k 22.87
2021-09-30 $272k 12k 22.13
2021-06-30 $1.8M 142k 12.98
2021-03-31 $1.6M 120k 13.00
2020-12-31 $1.5M 99k 14.68
2020-09-30 $1.5M 99k 14.68
2020-06-30 $1.3M 79k 16.18
2020-03-31 $1.1M 74k 14.35
2019-12-31 $1.1M 55k 20.27
2019-09-30 $88k 17k 5.34
2019-06-30 $88k 13k 6.61